By New Scientist ER Productions Limited/Getty Images With researchers, journals, politicians, journalists and social media influencers all capable of espousing misleading or unverified scientific findings, it pays to be able to recognise the telltale signs of a study that might be poor. Here are seven potential warning flags: Study is published on a blog, preprint…
April 16, 2020 | 10:00pm Dogs might join the good fight to prevent the spread of the coronavirus in humans–especially for those who are symptom free, according to a team of researchers. Due to the urgent need of coronavirus testing, preparations to intensively train dogs to detect asymptomatic carries of the virus have started and…
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.